跳至主要内容
临床试验/NCT04700475
NCT04700475Unknown不适用

Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.

Nada Yousef1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年9月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Unstimulated and stimulated salivary flow rate.

研究概览

简要总结

The purpose of the study is to evaluate the effectiveness of low level laser on radiotherapy induced xerostomia to improve oral function and decrease oral complication due to hyposalivation and thus enhancing survival.

详细描述

In this part of the study, the materials and methods will be presented under the following headings: subjects, equipment, procedures of the study and the statistical procedures.

  1. Subjects:

Sixty patients who have head and neck cancer (oral cavity, pharynx, larynx, or occult primary tumor) submitted to conventional 3D radiotherapy, with irradiation fields necessarily encompassing all major salivary glands. The total dose ranged from 66 to 70 Gy, given in fractions of 2 Gy/day selected randomly from Nuclear medicine department, Oncology institute, Mansoura University.

These patients will be divided randomly into two groups of equal number, thirty patients for each group.

Group A: (Laser group) This group of patients composes of thirty patients who will receive GaAlAs laser three times a week, on alternate day (48h interval) Laser therapy will be initiated before the first radiotherapy session and ended after the last session, totaling 21 sessions (Fernanda A. S.G. et al., 2016).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

The participants are head and neck cancer patients recieving radiotherapy. The care provider are oncologist and nursing stuff. The investigator is phsical therapist (my self)

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • - Age range between 25-55 years.
  • All patients included in the study established HNC and will receive radiotherapy encompassing major salivary glands accompanied or not by surgery.
  • All patients enrolled to the study will have their informed consent.
  • Both genders will participate in the study.
  • All the patients were examined medically by oncologist

排除标准

  • - Diabetes mellitus,
  • Autoimmune diseases as sjorgen syndrome by established diagnosis criteria.
  • Infectious diseases
  • Collagen diseases, as were those with incipient tumors (stage T1 or T2) limited to the larynx, as well as those with trismus (reduced mouth opening capacity) due to surgical sequelae.
  • xerostomic drugs (antiretroviral medications, antihistamines, anticholinergics, antihypertensives, decongestants, narcotic analgesics, tricyclic antidepressants)

研究组 & 干预措施

Laser group

Experimental

Laser group composes of thirty patients who will receive low level laser three times a week, on alternate day (48h interval) Laser therapy will be initiated before the first radiotherapy session and ended after the last session, totaling 21 sessions

干预措施: low level laser (Device)

Laser group

Experimental

Laser group composes of thirty patients who will receive low level laser three times a week, on alternate day (48h interval) Laser therapy will be initiated before the first radiotherapy session and ended after the last session, totaling 21 sessions

干预措施: citric acid solution (Drug)

Control group

Other

control group composes of thirty patients will be treated with 15mL of a 2% citric acid solution applied as a mouth rinse for 30 sec

干预措施: citric acid solution (Drug)

结局指标

主要结局

Unstimulated and stimulated salivary flow rate.

时间窗: 7 weeks

For the assessment of salivary flow rate, unstimulated and stimulated sialometry tests will be performed before the first radiotherapy session and after completion of laser programe. As salivary secretion fluctuates between minimal and maximal rates during the day, it is important to assess the salivary secretion consistently at an established time of the day, in order to properly examine the evolution of the condition and its treatment in every patient. The normal flow rate for unstimulated, "resting" whole saliva is 0.3 to 0.5 ml/min.; for stimulated saliva, 1 to 2 ml/min. Values less than 0.1 ml/min. are typically considered xerostomic, although reduced flow may not always be associated with complaints of dryness

次要结局

  • Salivary immunoglobin A (sIgA) concentration in unstimulated saliva.(7weeks)

研究者

发起方
Nada Yousef
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nada Yousef

Assistant lecturer of physical therapy, cairouniversity

Cairo University

研究点 (1)

Loading locations...

相似试验